Tauroursodeoxycholic acid targets HSP90 to promote protein homeostasis and extends healthy lifespan

Jia-Yu Liu,Yao Wang,Yue Guo,Run-Qi Zheng,Yun-Ying Wang,Yan-Yan Shen,Yan-Hong Liu,Ai-Ping Cao,Rui-Bo Wang,Bo-Yang Xie,Shuai Jiang,Qiu-Ying Han,Jing Chen,Fang-Ting Dong,Kun He,Na Wang,Xin Pan,Tao Li,Tao Zhou,Ai-Ling Li,Qing Xia,Wei-Na Zhang
DOI: https://doi.org/10.1007/s11427-024-2717-6
2024-09-28
Science China Life Sciences
Abstract:As the elderly population expands, the pursuit of therapeutics to reduce morbidity and extend lifespan has become increasingly crucial. As an FDA-approved drug for chronic cholestatic liver diseases, tauroursodeoxycholic acid (TUDCA), a natural bile acid, offers additional health benefits beyond liver protection. Here, we show that TUDCA extends the lifespan and healthspan of C. elegans . Importantly, oral supplementation of TUDCA improves fitness in old mice, including clinically relevant phenotypes, exercise capacity and cognitive function. Consistently, TUDCA treatment drives broad transcriptional changes correlated with anti-aging characteristics. Mechanistically, we discover that TUDCA targets the chaperone HSP90 to promote its protein refolding activity. This collaboration further alleviates aging-induced endoplasmic reticulum (ER) stress and facilitates protein homeostasis, thus offering resistance to aging. In summary, our findings uncover new molecular links between an endogenous metabolite and protein homeostasis, and propose a novel anti-aging strategy that could improve both lifespan and healthspan.
biology
What problem does this paper attempt to address?